Abera Bioscience
Chemicals & Related Products · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Stureplan Stockholm 15, Stockholm, Stock...Phone Number
+46 722311797Website
www.aberabio.comRevenue
<$5 MillionIndustry
About Abera Bioscience
Is Abera Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Abera Bioscience recently announced quarterly report
Check out if Abera Bioscience is spiking on competitors!
Funding: Get notified immidiatlly once Abera Bioscience has new funding data
Congratulate Masked Content for being promoted to Masked Content at Abera Bioscience
Product Launch: Get notified when Abera Bioscience launches new products
Click to see if Abera Bioscience had a recent Job posting/layoffs
Check if Abera Bioscience has recently received funding, and reach out quickly before it becomes old news!
Abera Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Abera Bioscience
Find 2 more new buyers
Company Profile Activity
Activity Insights
Abera Bioscience is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abera Bioscience is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abera Bioscience.
Abera Bioscience Tech Stack
A closer look at the technologies used by Abera Bioscience
Abera Bioscience News & Media
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abera Bioscience
Abera Bioscience is a Swedish biotechnology company focused on developing next-generation nasal vaccines utilizing a modular OMV platform. Their innovative technology allows for rapid design and cost-effective production of vaccines that induce strong mucosal and systemic immunity. The company's pipeline includes a serotype-independent nasal pneumo... Read More